Kazam Joshua A
Insider CIK 1221355 · NLTX President & CEO, Director · KITE Director · EAGL Director · ALLO Director · KRON Director · DEAC Director · LTCH · TSIB Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2026-06-18 | 2026-06-23 | 95,400 | — | $0 | 95,400 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | M Exercise deriv | 2026-06-18 | 2026-06-23 | 47,700 | — | $0 | 0 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | M Exercise | 2026-06-18 | 2026-06-23 | 47,700 | — | $0 | 398,463 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | M Exercise deriv | 2025-12-18 | 2025-12-22 | 47,700 | — | $0 | 47,700 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | M Exercise | 2025-12-18 | 2025-12-22 | 47,700 | — | $0 | 350,763 | SEC↗ |
| KRON Kronos Bio, Inc. | D To issuer deriv | 2025-06-20 | 2025-06-20 | 34,000 | — | $0 | 0 | SEC↗ |
| KRON Kronos Bio, Inc. | D To issuer deriv | 2025-06-20 | 2025-06-20 | 20,600 | — | $0 | 0 | SEC↗ |
| KRON Kronos Bio, Inc. | D To issuer deriv | 2025-06-20 | 2025-06-20 | 34,000 | — | $0 | 0 | SEC↗ |
| KRON Kronos Bio, Inc. | D To issuer deriv | 2025-06-20 | 2025-06-20 | 34,000 | — | $0 | 0 | SEC↗ |
| KRON Kronos Bio, Inc. | U Tender | 2025-06-20 | 2025-06-20 | 94,481 | $0.57 | $53.9K | 0 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2025-06-18 | 2025-06-23 | 94,500 | — | $0 | 94,500 | SEC↗ |
| KRON Kronos Bio, Inc. | A Award deriv | 2024-06-25 | 2024-06-26 | 34,000 | — | $0 | 34,000 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2024-06-05 | 2024-06-07 | 191,082 | — | $0 | 191,082 | SEC↗ |
| KRON Kronos Bio, Inc. | A Award deriv | 2023-06-22 | 2023-06-26 | 34,000 | — | $0 | 34,000 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2023-06-13 | 2023-06-15 | 116,120 | — | $0 | 116,120 | SEC↗ |
| KRON Kronos Bio, Inc. | A Award deriv | 2022-06-22 | 2022-06-29 | 34,000 | — | $0 | 34,000 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award | 2022-06-15 | 2022-06-17 | 44,178 | — | $0 | 303,063 | SEC↗ |
| KRON Kronos Bio, Inc. | G Gift | 2022-03-07 | 2022-03-09 | 211,000 | — | $0 | 305,481 | SEC↗ |
| KRON Kronos Bio, Inc. | G Gift | 2022-03-07 | 2022-03-09 | 211,000 | — | $0 | 94,481 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | G Gift | 2022-03-07 | 2022-03-09 | 412,618 | — | $0 | 258,885 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | J Other | 2022-03-07 | 2022-03-09 | 412,618 | — | $0 | 671,503 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | P Buy | 2022-01-12 | 2022-01-14 | 15,000 | $12.60 | $189.0K | 258,885 | SEC↗ |
| KRON Kronos Bio, Inc. | A Award deriv | 2021-06-22 | 2021-06-23 | 20,600 | — | $0 | 20,600 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | G Gift | 2021-06-11 | 2021-06-11 | 500,000 | — | $0 | 243,885 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award | 2021-06-10 | 2021-06-11 | 16,498 | — | $0 | 743,885 | SEC↗ |
| LTCH TS Innovation Acquisitions | M Exercise deriv | 2021-06-04 | 2021-06-07 | 30,000 | — | $0 | 0 | SEC↗ |
| LTCH TS Innovation Acquisitions | M Exercise | 2021-06-04 | 2021-06-07 | 30,000 | — | $0 | 30,000 | SEC↗ |
| TSIB Tishman Speyer Innovation | P Buy deriv | 2021-02-12 | 2021-02-16 | 5,000 | — | $0 | 5,000 | SEC↗ |
| TSIB Tishman Speyer Innovation | P Buy | 2021-02-12 | 2021-02-16 | 25,000 | — | $0 | 25,000 | SEC↗ |
| KRON Kronos Bio, Inc. | C Conversion deriv | 2020-10-14 | 2020-10-16 | 65,228 | — | $0 | 0 | SEC↗ |
| KRON Kronos Bio, Inc. | C Conversion deriv | 2020-10-14 | 2020-10-16 | 22,328 | — | $0 | 0 | SEC↗ |
| KRON Kronos Bio, Inc. | C Conversion | 2020-10-14 | 2020-10-16 | 23,556 | — | $0 | 25,666 | SEC↗ |
| KRON Kronos Bio, Inc. | C Conversion | 2020-10-14 | 2020-10-16 | 68,815 | — | $0 | 94,481 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award | 2020-06-05 | 2020-06-09 | 9,969 | — | $0 | 1,033,305 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | J Other | 2020-04-24 | 2020-04-28 | 8,039 | — | $0 | 1,023,336 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | J Other | 2020-03-04 | 2020-03-11 | 8,217 | — | $0 | 1,015,297 | SEC↗ |
| DEAC Diamond Eagle Acquisition | J Other deriv | 2019-12-31 | 2019-12-31 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | J Other | 2019-11-19 | 2019-11-21 | 8,217 | — | $0 | 1,453,703 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | G Gift | 2019-11-11 | 2019-11-21 | 446,623 | — | $0 | 1,007,080 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | J Other | 2019-10-25 | 2019-10-29 | 8,217 | — | $0 | 1,445,486 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | J Other | 2019-09-23 | 2019-09-25 | 8,217 | — | $0 | 1,437,269 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | J Other | 2019-09-05 | 2019-09-09 | 8,217 | — | $0 | 1,429,052 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | J Other | 2019-07-18 | 2019-07-22 | 8,217 | — | $0 | 1,420,835 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | J Other | 2019-07-10 | 2019-07-12 | 5,590 | — | $0 | 1,412,618 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award | 2019-06-06 | 2019-06-24 | 16,377 | — | $0 | 1,407,028 | SEC↗ |
| EAGL Platinum Eagle Acquisition | P Buy | 2019-03-05 | 2019-03-05 | 5,000 | $10.20 | $51.0K | 10,000 | SEC↗ |
| EAGL Platinum Eagle Acquisition | P Buy | 2019-03-01 | 2019-03-01 | 5,000 | $10.13 | $50.7K | 5,000 | SEC↗ |
| EAGL Platinum Eagle Acquisition | P Buy deriv | 2019-01-22 | 2019-01-22 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | C Conversion deriv | 2018-10-15 | 2018-10-17 | 3,565 | — | $0 | 0 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | C Conversion | 2018-10-15 | 2018-10-17 | 18,716 | — | $0 | 1,390,651 | SEC↗ |
| EAGL Platinum Eagle Acquisition | A Award deriv | 2018-01-17 | 2018-01-18 | 333,334 | $1.50 | $500.0K | 333,334 | SEC↗ |
| CAPR CAPRICOR THERAPEUTICS, INC | A Award deriv | 2018-01-02 | 2018-01-04 | 18,000 | — | $0 | 18,000 | SEC↗ |
| KITE Kite Pharma, Inc. | D To issuer deriv | 2017-10-03 | 2017-10-05 | 50,000 | $178.65 | $8.93M | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | D To issuer deriv | 2017-10-03 | 2017-10-05 | 10,000 | $120.77 | $1.21M | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | D To issuer deriv | 2017-10-03 | 2017-10-05 | 7,000 | $129.13 | $903.9K | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | D To issuer deriv | 2017-10-03 | 2017-10-05 | 8,810 | $88.79 | $782.2K | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | D To issuer | 2017-10-03 | 2017-10-05 | 70,050 | $180.00 | $12.61M | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | U Tender | 2017-10-03 | 2017-10-05 | 2,553 | $180.00 | $459.5K | 1,807 | SEC↗ |
| KITE Kite Pharma, Inc. | D To issuer | 2017-10-03 | 2017-10-05 | 1,807 | — | $0 | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | J Other | 2017-09-28 | 2017-10-05 | 70,050 | — | $0 | 70,050 | SEC↗ |
| KITE Kite Pharma, Inc. | A Award deriv | 2017-06-20 | 2017-06-22 | 8,810 | — | $0 | 8,810 | SEC↗ |
| KITE Kite Pharma, Inc. | A Award | 2017-06-20 | 2017-06-22 | 2,410 | — | $0 | 4,360 | SEC↗ |
| CAPR CAPRICOR THERAPEUTICS, INC | A Award deriv | 2017-01-03 | 2017-01-04 | 16,060 | — | $0 | 16,060 | SEC↗ |
| CAPR CAPRICOR THERAPEUTICS, INC | A Award deriv | 2016-06-02 | 2016-06-06 | 15,000 | — | $0 | 15,000 | SEC↗ |
| KITE Kite Pharma, Inc. | A Award deriv | 2016-06-01 | 2016-06-03 | 7,000 | — | $0 | 7,000 | SEC↗ |
| KITE Kite Pharma, Inc. | A Award | 2016-06-01 | 2016-06-03 | 1,950 | — | $0 | 216,950 | SEC↗ |
| KITE Kite Pharma, Inc. | A Award deriv | 2015-06-09 | 2015-06-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CAPR CAPRICOR THERAPEUTICS, INC | A Award deriv | 2015-03-03 | 2015-03-05 | 7,500 | — | $0 | 7,500 | SEC↗ |
| CAPR CAPRICOR THERAPEUTICS, INC | P Buy | 2015-01-21 | 2015-01-22 | 7,096 | $3.52 | $25.0K | 38,084 | SEC↗ |
| KITE Kite Pharma, Inc. | C Conversion deriv | 2014-06-25 | 2014-06-27 | 40,000 | — | $0 | 40,000 | SEC↗ |
| KITE Kite Pharma, Inc. | C Conversion deriv | 2014-06-25 | 2014-06-27 | 40,000 | — | $0 | 0 | SEC↗ |
| CAPR CAPRICOR THERAPEUTICS, INC | A Award deriv | 2014-05-09 | 2014-05-15 | 83,661 | — | $0 | 83,661 | SEC↗ |
| CAPR CAPRICOR THERAPEUTICS, INC | H Expire deriv | 2013-11-20 | 2014-01-28 | 1,875 | — | $0 | 0 | SEC↗ |
| CAPR CAPRICOR THERAPEUTICS, INC | J Other | 2013-11-20 | 2014-01-28 | 1,875 | — | $0 | 30,988 | SEC↗ |
| CAPR CAPRICOR THERAPEUTICS, INC | H Expire deriv | 2013-11-13 | 2014-01-28 | 988 | — | $0 | 0 | SEC↗ |
| CAPR CAPRICOR THERAPEUTICS, INC | H Expire deriv | 2013-11-13 | 2014-01-28 | 633 | — | $0 | 0 | SEC↗ |
| CAPR CAPRICOR THERAPEUTICS, INC | H Expire deriv | 2013-11-13 | 2014-01-28 | 1,976 | — | $0 | 0 | SEC↗ |
| CAPR CAPRICOR THERAPEUTICS, INC | H Expire deriv | 2013-11-13 | 2014-01-28 | 988 | — | $0 | 0 | SEC↗ |
| CAPR CAPRICOR THERAPEUTICS, INC | J Other | 2013-11-13 | 2014-01-28 | 50 | — | $0 | 29,113 | SEC↗ |
| NLTX Nile Therapeutics, Inc. | P Buy deriv | 2012-03-30 | 2012-04-02 | 93,750 | — | $0 | 93,750 | SEC↗ |
| NLTX Nile Therapeutics, Inc. | P Buy | 2012-03-30 | 2012-04-02 | 125,000 | — | $0 | 1,453,228 | SEC↗ |